CN Patent

CN1290893C — 聚合物微乳状液

Assigned to Janssen Pharmaceutica NV · Expires 2006-12-20 · 19y expired

What this patent protects

本发明提供一种新颖的自乳化二嵌段共聚物以及新颖的含有活性成分和二嵌段共聚物的自乳化组合物，其特征在于该二嵌段共聚物在低于50℃的温度下为液态，且该组合物在低于50℃的温度为非水性和液态。

USPTO Abstract

本发明提供一种新颖的自乳化二嵌段共聚物以及新颖的含有活性成分和二嵌段共聚物的自乳化组合物，其特征在于该二嵌段共聚物在低于50℃的温度下为液态，且该组合物在低于50℃的温度为非水性和液态。

Drugs covered by this patent

Patent Metadata

Patent number
CN1290893C
Jurisdiction
CN
Classification
—
Expires
2006-12-20
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.